LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,551,320 | -2.7% | 38,000 | 0.0% | 0.86% | +7.5% |
| Q2 2023 | $2,623,140 | +43.0% | 38,000 | 0.0% | 0.80% | +56.1% |
| Q1 2023 | $1,833,880 | -3.2% | 38,000 | 0.0% | 0.51% | -12.5% |
| Q4 2022 | $1,894,300 | +22.1% | 38,000 | 0.0% | 0.58% | +17.7% |
| Q3 2022 | $1,551,000 | -65.5% | 38,000 | +15222.6% | 0.50% | +957.4% |
| Q2 2022 | $4,500,000 | -20.1% | 248 | -94.5% | 0.05% | -96.3% |
| Q1 2022 | $5,632,000 | +2594.7% | 4,500 | 0.0% | 1.27% | +2602.1% |
| Q4 2021 | $209,000 | -91.6% | 4,500 | -90.9% | 0.05% | -92.2% |
| Q3 2021 | $2,497,000 | – | 49,500 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |